Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC

Published Date: 13 Sep 2024

However, plinabulin plus docetaxel still "not ready for prime time," expert says

Read Full News

Todays Updates


Third Molar Extraction: Benefit or Overtreatment?


Third molar removal may improve oral health markers, but its benefits must be weighed against surgical risks, postoperative morbidity, and cost.

Stopping Aspirin Early May Cut Bleeding Risk After Stents


Stopping aspirin early in dual antiplatelet therapy is tied to a lower risk for bleeding with no increase in ischemic risks after coronary stenting, a new meta-analysis finds.

WHO Declares Hantavirus Outbreak Linked to Cruise Ship Over


The World Health Organization ⁠on Thursday declared the hantavirus ⁠outbreak linked to a ⁠cruise ship ‌over after the last identified contact of an exposed person completed...

Australia's New South Wales Confirms H5N1 Bird Flu Case, Third State


New South Wales became Australia's third state to confirm a case of H5N1 bird flu after authorities said ⁠a migratory seabird found near a coastal town returned a positive...

Effort to End Respiratory Viruses to Start With Cold & Flu


The $500 million seed fund will support universal antiviral platforms and air cleaning technologies.

Professional Corner: Resident Well-Being, Maternity, & More


New study finds nearly 10% of internal medicine residents report a disability; the American Medical Association updates maternity care billing codes; and Texas joins autism trial network.

Venetoclax-Obinutuzumab Boosts MRD Clearance in CLL


A phase 3 trial compares first-line fixed-duration venetoclax-obinutuzumab to fludarabine, cyclophosphamide, and rituximab/bendamustine-rituximab in patients with CLL.

Todays Updates


Third Molar Extraction: Benefit or Overtreatment?


Third molar removal may improve oral health markers, but its benefits must be weighed against surgical risks, postoperative morbidity, and cost.

Stopping Aspirin Early May Cut Bleeding Risk After Stents


Stopping aspirin early in dual antiplatelet therapy is tied to a lower risk for bleeding with no increase in ischemic risks after coronary stenting, a new meta-analysis finds.

WHO Declares Hantavirus Outbreak Linked to Cruise Ship Over


The World Health Organization ⁠on Thursday declared the hantavirus ⁠outbreak linked to a ⁠cruise ship ‌over after the last identified contact of an exposed person completed...

Australia's New South Wales Confirms H5N1 Bird Flu Case, Third State


New South Wales became Australia's third state to confirm a case of H5N1 bird flu after authorities said ⁠a migratory seabird found near a coastal town returned a positive...

Effort to End Respiratory Viruses to Start With Cold & Flu


The $500 million seed fund will support universal antiviral platforms and air cleaning technologies.

Professional Corner: Resident Well-Being, Maternity, & More


New study finds nearly 10% of internal medicine residents report a disability; the American Medical Association updates maternity care billing codes; and Texas joins autism trial network.

Venetoclax-Obinutuzumab Boosts MRD Clearance in CLL


A phase 3 trial compares first-line fixed-duration venetoclax-obinutuzumab to fludarabine, cyclophosphamide, and rituximab/bendamustine-rituximab in patients with CLL.

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Ketamine plus psychotherapy for "excellent" PTSD

2.

Next Day Mood Is Affected by Ability to Recover From Work.

3.

Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients

4.

Adjuvant Belzutifan Combo Is ‘Practice Changing’ in RCC

5.

Numerous Oncologists Are Concerned About the Cost of Genomic Testing.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot